Table 6: Effect of changing the screening scenario from the baseline of biennial screening in women aged 50-74 years
Scenario*Modelled overall health care system cost, $Modelled life-yearsModelled QALYsHealth care system incremental cost, $Incremental cost-effectiveness ratio, $/life-yearIncremental cost-utility ratio, $/QALY
Increasing
Biennial 50-74 yr4 217 27530 66925 053
Annual 50-69 yr5 250 45830 68825 0691 033 18354 86262 549
Annual 50-74 yr5 789 12630 69425 075Weakly dominated
Annual 40-49 yr, biennial 50-69 yr6 072 75830 69725 078Weakly dominated
Annual 40-49 yr; biennial 50-74 yr6 444 99930 70325 083Weakly dominated
Annual 40-69 yr7 516 63030 72125 0982 266 17268 18479 266
Annual 40-74 yr8 051 76630 72725 103535 13688 088110 994
Decreasing
Biennial 50-74 yr4 217 27530 66925 053
Biennial 50-69 yr3 835 72630 66225 048381 54961 29677 307.62
Triennial 50-74 yr3 642 49430 65325 039Weakly dominatedWeakly dominated
Triennial 50-69 yr3 368 22530 64825 036467 50131 95838 142
No screening1 965 89930 60224 9981 402 32630 53636 981

Note: QALY = quality-adjusted life-year.

*Increasing = scenarios in which screening is increased from baseline; decreasing = scenarios in which screening is decreased from baseline. Incremental cost-effectiveness ratios and cost-utility ratios express dollars saved per life-year or QALY lost.